Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127527411 | 12752741 | 1 | I | 20160901 | 20160916 | 20160916 | EXP | FR-CIPLA LTD.-2016FR18128 | CIPLA | GARCIA M, LE MOAL G, GODET C, BERAUD G, CHAGNEAU-DERRODE C, ROBLOT F. FIRST CASE REPORT OF RENAL IMPROVEMENT ON TENOFOVIR ALAFENAMIDE IN AN HIV/HEPATITIS B VIRUS-COINFECTED PATIENT WITH ADEFOVIR-INDUCED FANCONI^S SYNDROME. AIDS. 2016;30:1487 TO 1493 | 0.00 | Y | 0.00000 | 20160916 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127527411 | 12752741 | 1 | PS | Tenofovir | TENOFOVIR | 1 | Unknown | UNK | Y | U | 78800 | ||||||||
127527411 | 12752741 | 2 | SS | Tenofovir | TENOFOVIR | 1 | Y | U | 78800 | ||||||||||
127527411 | 12752741 | 3 | SS | RITONAVIR. | RITONAVIR | 1 | Unknown | UNK | Y | U | 0 | ||||||||
127527411 | 12752741 | 4 | SS | RITONAVIR. | RITONAVIR | 1 | Y | U | 0 | ||||||||||
127527411 | 12752741 | 5 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
127527411 | 12752741 | 6 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | U | U | 0 | ||||||||||
127527411 | 12752741 | 7 | SS | Darunavir | DARUNAVIR | 1 | Unknown | UNK | Y | U | 0 | ||||||||
127527411 | 12752741 | 8 | SS | Darunavir | DARUNAVIR | 1 | Y | U | 0 | ||||||||||
127527411 | 12752741 | 9 | SS | ENTECAVIR. | ENTECAVIR | 1 | Unknown | UNK | U | U | 0 | ||||||||
127527411 | 12752741 | 10 | SS | ENTECAVIR. | ENTECAVIR | 1 | U | U | 0 | ||||||||||
127527411 | 12752741 | 11 | SS | Atazanavir | ATAZANAVIR | 1 | Unknown | UNK | Y | U | 0 | ||||||||
127527411 | 12752741 | 12 | SS | Atazanavir | ATAZANAVIR | 1 | Y | U | 0 | ||||||||||
127527411 | 12752741 | 13 | SS | ADEFOVIR DIPIVOXIL. | ADEFOVIR DIPIVOXIL | 1 | Unknown | 10 MG, PER DAY | Y | U | 0 | 10 | MG | ||||||
127527411 | 12752741 | 14 | SS | ADEFOVIR DIPIVOXIL. | ADEFOVIR DIPIVOXIL | 1 | Y | U | 0 | ||||||||||
127527411 | 12752741 | 15 | SS | Etravirine | ETRAVIRINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
127527411 | 12752741 | 16 | SS | Etravirine | ETRAVIRINE | 1 | U | U | 0 | ||||||||||
127527411 | 12752741 | 17 | SS | NORVIR | RITONAVIR | 1 | Unknown | UNK | U | U | 0 | ||||||||
127527411 | 12752741 | 18 | SS | NORVIR | RITONAVIR | 1 | U | U | 0 | ||||||||||
127527411 | 12752741 | 19 | SS | Telbivudine | TELBIVUDINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
127527411 | 12752741 | 20 | SS | Telbivudine | TELBIVUDINE | 1 | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127527411 | 12752741 | 1 | HIV infection |
127527411 | 12752741 | 2 | Hepatitis B |
127527411 | 12752741 | 3 | HIV infection |
127527411 | 12752741 | 4 | Hepatitis B |
127527411 | 12752741 | 5 | HIV infection |
127527411 | 12752741 | 6 | Hepatitis B |
127527411 | 12752741 | 7 | HIV infection |
127527411 | 12752741 | 8 | Hepatitis B |
127527411 | 12752741 | 9 | HIV infection |
127527411 | 12752741 | 10 | Hepatitis B |
127527411 | 12752741 | 11 | HIV infection |
127527411 | 12752741 | 12 | Hepatitis B |
127527411 | 12752741 | 13 | HIV infection |
127527411 | 12752741 | 14 | Hepatitis B |
127527411 | 12752741 | 15 | HIV infection |
127527411 | 12752741 | 16 | Hepatitis B |
127527411 | 12752741 | 17 | HIV infection |
127527411 | 12752741 | 18 | Hepatitis B |
127527411 | 12752741 | 19 | HIV infection |
127527411 | 12752741 | 20 | Hepatitis B |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127527411 | 12752741 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127527411 | 12752741 | Drug resistance | |
127527411 | 12752741 | Fanconi syndrome | |
127527411 | 12752741 | Osteonecrosis | |
127527411 | 12752741 | Osteoporosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |